| 产品名称 | Peptides EP09856_1 | MOG 1 - 26, human |
|---|---|
| 目录号 | EP09856_1 |
| 别名 | MOG 1 - 26, human |
| 外观 | 见COA |
| 分子量 | N/A |
| CAS | N/A |
| 溶解度 | |
| 存储条件 | 见COA |
| 保存时间 | 见COA |
| 备注1 | |
| 备注2 |
| 目录号 | 规格 | 价格 | 库存状态 | |
| EP09856_1 | 1 mg; 5 mg | 咨询 | 咨询 |
Peptides EP09856_1 | MOG 1 - 26, human
品名：MOG 1 - 26, human
货号：EP09856_1
规格：1 mg; 5 mg
品牌：Peptides.de
产品描述
Myelin oligodendrocyte glycoprotein (MOG) 1 - 26, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is believed to be a target autoantigen in multiple sclerosis. MOG 1 - 26 peptide is an immunodominant epitope of MOG that induces strong T and B cell responses and Induces experimental autoimmune encephalomyelitis in rodents. A single injection of this peptide produces a relapsing-remitting neurologic disease with extensive plaque-like demyelination. This Cysteine containing MOG (1 - 26) peptide can be use to induced polyclonal anti-MOG(1 - 26) antibody production in rabbits with high specificity, high affinity, and high titer indicating its high purity, as well as suitability for peptide-coated ELISA and Western blot assay. Immunization with MOG (1 - 26) suppresses spontaneous regeneration of dopaminergic neurons injured with MPTP.
| Protein | Myelin-oligodendrocyte glycoprotein |
| Species | Human |
| Indication | Neuroscience |
